Used in research settings as a selective antagonist for the P2X7 receptor, involved in studying inflammatory responses and neuroimmune interactions. Shows potential in exploring treatments for chronic pain, neurodegenerative diseases, and autoimmune disorders. Primarily utilized in preclinical in vitro and in vivo models to modulate purinergic signaling pathways. Not approved for clinical or therapeutic use. Handle only by trained personnel in controlled laboratory environments.